IGF1 and COVID-19: Zhao et al. found that IGF1 signaling from immune cells was altered during recovery from COVID-19 and that serum IGF1 declined after viral clearance [107], while Feizollahi et al. reported no overall difference in IGF-1 between severe COVID-19 patients and controls but observed correlations of IGF-1 with age and clinical features [105].